CONMED Corporation (CNMD), a medical technology company, announced the appointment of John E. Gallagher as Chief Financial Officer (CFO), effective July 15, 2026. He will succeed current CFO Todd Garner.
Garner will remain at the company in an advisory capacity till November 2, 2026.
Gallagher brings more than 30 years of experience in corporate finance across public healthcare and industrial companies to the job, serving as CFO of Certara, Inc. since 2023, and formerly at Cue Health Inc. from 2021 to 2023. He previously held the position of Senior Vice President, Corporate Treasurer, and Chief Financial Officer of Becton, Dickinson & Co. (BD), facilitating two acquisitions during his tenure.
CNMD closed Wednesday's trade at $32.11, down 7.12%.
For more such biotech stock news, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.